Hi-Tech Pharmaceuticals Critical Mass 5lb | For Hard Gainers
Building muscle and bulking up is not a simple task for some people, no matter how much they eat and how much they lift they just can't seem to put on weight. To develop significant muscle mass you need to consume more calories than you burn. Hi-Tech Pharmaceuticals Critical Mass is specifically created for Hard Gainers. This high calorie protein matrix features 50 grams of protein, 75 grams of carbs, 10 grams of fats, and 610 calories per serving.
Hi-Tech Pharmaceuticals Critical Mass Highlights
- 50 Grams of Protein
- 75 Grams Carbs
- 10 Grams Fats
- Clean Fuel for Hard Gainers
- Most Complete High Calorie Blend Ever Made
Hi-Tech Pharmaceuticals Features
- Whole Food Carbs
- Oats and Quinoa
- MCT Fats
Directions
Mix 1 serving (2 scoops) with 14-20 oz (400-600mL) of water or milk, 1-3 times per day. Drink Critical Mass upon waking, post-workout, and/or before bed.
Hi-Tech Pharmaceuticals Critical Mass 5lb Supplement Facts
Warnings
Do not use as a sole source of nutrition. Do not use if seal or broken or missing. Keep out of reach of children. Check with a qualified healthcare professional before taking this product. Keep away from children. FDR Adult use only. Settling may occur. Keep in a cool dry place.
References
Helms ER, Aragon AA, Fitschen PJ. Evidence-based recommendations for natural bodybuilding contest preparation: nutrition and supplementation. J Int Soc Sports Nutr. 2014;11:20. Published 2014 May 12. doi:10.1186/1550-2783-11-20
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033492/
Iraki J, Fitschen P, Espinar S, Helms E. Nutrition Recommendations for Bodybuilders in the Off-Season: A Narrative Review. Sports (Basel). 2019;7(7):154. Published 2019 Jun 26. doi:10.3390/sports7070154
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680710/
Stark M, Lukaszuk J, Prawitz A, Salacinski A. Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training. J Int Soc Sports Nutr. 2012;9(1):54. Published 2012 Dec 14. doi:10.1186/1550-2783-9-54
